If you’ve never heard of Donna Walton, that’s ok because you’re learning about her now.
Donna Walton is one of the millions of people who have lived through having cancer and gone on to live a fulfilling and meaningful life. In Donna’s case, 30 years after she had her leg amputated above the knee because of cancer, she is a certified cognitive behavioral therapist and she works as a consultant and motivational speaker.
You can read more about Donna’s achievements and work over at Disaboom.com: Amputee and Cancer Survivor: Donna Walton Walks Her Talk.
~~~
Tags: donna walton, cancer survivor, cognitive behavior therapist, …read more

While cryoablation is working wonders in kidney cancer patients will unoperable tumors, the procedure has been found to offer durable pain relief of cancer that has spread to the bone – according to Mayo Clinic.
According to Matthew Callstrom, M.D., Ph.D., a radiologist at Mayo Clinic who presented his latest findings on cryoablation for pain management at the Radiological Society of North America (RSNA) annual meeting this week (Nov. 27):
“Cancer patients are living longer and we need to be able to manage their pain over a long period of time.
Two key parts of this study are that the reduction in pain …read more

Multiple myeloma is a cancer of the bone that currently has no cure.
In a new phase I clinical trial opened by Mayo Clinic Cancer Center, a bioengineered measles virus is being tested of its potential to kill cancer.
This the third of a series of molecular medicine studies in patients testing the potential of measles to kill cancer. Previous studies were on glioblastoma multiforme (a brain tumor) and recurrent ovarian cancer.
Many cancers, including multiple myeloma, overexpress a protein, CD46, which allows them to evade destruction by the immune system. Laboratory strains of measles virus seek out this protein and use it as …read more

Compared to standard doses of chemotherapy, a dose-intensive regimen of cisplatin and doxorubicin offered no clinical benefit in patients with the bone cancer osteosarcoma.
Such were the findings of a randomized clinical trial whose data has been reported in the January 17 issue of the Journal of the National Cancer Institute.
In other cancers such as non-Hodgkin lymphoma and breast cancer, increasing the intensity of a chemotherapy regimen (means decreasing the number of days between chemotherapy treatments) may improve survival, as been shown in previous studies.
But that wasn’t the case in osteosarcoma: while the dose-intensive regimen killed tumor cells better than the …read more